Science & Technology
ABHI UK HealthTech Conference 2025
Join us at the ABHI UK HealthTech Conference 2025 – Your Gateway to Market Access and Regulatory Insight.
The ABHI UK HealthTech Conference will explore the most pressing themes shaping our industry – with a focus on UK market access and regulation. Designed to equip your business with a clear understanding of the national landscape, the event brings together leading experts, policymakers, and industry figures for two days of invaluable insight, discussion, and networking.
The UK has an ambition to become the most attractive place in the world to launch and scale HealthTech innovation. Yet, the path to adoption remains complex, and navigating regulatory requirements is still a significant barrier for many. In direct response, the 2025 Conference will provide a deep dive into these critical issues – spotlighting the latest policy developments and offering a platform for direct engagement with the individuals and institutions driving change.
Day One will focus on UK market access, exploring the frameworks, pathways, and partnerships needed to bring technologies into the NHS and wider health system.
Day Two will turn the spotlight on regulation, covering current reforms, international alignment, and future opportunities for innovation-friendly frameworks.
With 200+ participants expected each day, this is an unmissable opportunity to connect with peers, gain practical knowledge, and identify the growth opportunities shaping the future of HealthTech.
Don't miss out on your chance to be part of UK HealthTech's key event.
Agenda - 11th November 2025
08:30 – Registration & Coffee
09:15 – Welcome
Luella Trickett - Executive Director, Medical Devices, Value and Access, ABHI
09:25 – Introduction
Peter Ellingworth - Chief Exective, ABHI
09:30 – Keynote Address
Lord Ara Darzi - Paul Hamlyn Chair of Surgery, Imperial College
09:50 – Policy to Practice
TBC
10:00–10:20 – Life Sciences Sector Plan
Panel Q&A
TBC
Dr Sarah Byron - Programme Director for Healthtech Strategy and Development, NICE
10:30 – Keynote Address
Sir Jim Mackey - CEO, NHS England
10:45 – Coffee Break
11:15 – Virtual Wards
Dr Niall Keenan - Consultant Cardiologist, West Hertfordshire Teaching Hospitals NHS Trust
11:40 – Decentralised Diagnostics
Debra Padgett - Clinical Pathology Head of Service, Northumbria Healthcare NHS Foundation Trust NENC Pathology Network Operational Lead
Matthew Johnson - Director of Access & Innovation, Roche Diagnostics
12:10 – Future of Part IX
David Lawson - Director, MedTech Directorate, Department of Health and Social Care
12:30 – Lunch
13:30 – Early Diagnosis
Elizabeth Hampson - Partner, Deloitte
13:55 – Prevention Programme
Colette Marshall - CEO, Diabetes UK
14:20 – Policy and Innovation in Preventive Health
Adam Bradshaw - Senior Policy Advisor, Policy & Politics, Tony Blair Institute
Tim Bennett - Associate Director, UK & Ireland Government Affairs, Illumina
14:45 – Coffee Break
15:15 – Policy Overview
TBC
15:30 – Data Infrastructure
Ming Tang - Chief Data and Analytics Officer, NHS England
15:45 – AI Pathology
Dr Prabs Arumugam - Clinical Innovation Lead, AWS
16:00 – Q&A Session with Ming Tang & Dr Arumugam
16:15 – The Patient Perspective
Jacob Lant - CEO, National Voices
16:35 – Industry Panel
Chair: Dr Chris Laing - CEO, UCL Partners
Ushma Baros - Commercial Director, Big Health
Matt Press - CEO, Kimal
Shona Macdonald - Director of Market access & Reimbursement, UKI, Convatec
Kristian Howells - Group Commercial Director, Medtronic UKI
Mike Cullen – Head of Value & Access, BBraun
16:55 – Closing Remarks
Luella Trickett - Executive Director, Medical Devices, Value and Access, ABHI
17:00 – Event Close
12th November 2025
08:30 – Registration & Coffee
09:25 – Welcome
Phil Brown - Director, Regulatory & Compliance, ABHI
09:35 – Introduction
Peter Ellingworth - Chief Exective, ABHI
09:40 – Topical Challenges Facing Diagnostics in the NHS
Chris Sleight - Founder and CEO, Ex Chief Officer of the Greater Manchester Diagnostics Network
10:00 – Keynote
Lawrence Tallon - CEO, MHRA
10:45 – Coffee Break
11:15 – Regulatory Impact: Regulation & Standards as a Facilitator
David Lawson - Director, MedTech Directorate, Department of Health and Social Care
Dr Samantha Atkinson – CEO, TOPRA
Tony Bellis - Head of Government Affairs, UK & EMEA, Solventum (formerly 3M)
Mark Grumbridge - Head of Clinical Investigations, MHRA
12:00 – MHRA Roadmaps
Rob Reid - Deputy Director, Innovative Devices, MHRA
12:30 – Lunch
13:30 – Introductions
Steve Lee - Director, Diagnostics and Digital Regulation, ABHI
13:35 – Post Market Surveillance: Member Experiences & Panel Discussion
Darren Thain - Director, Global Regulatory Policy and Intelligence · Smith+Nephew
Claire Huntington - Head of Quality and Regulatory Affairs, Pennine Healthcare
Mike King - Senior Director, Product & Strategy, MedTech, IQVIA
James Dewar - CEO, Scarlet
14:20 – Clinical Research
Alessandro Malaspina - Head of Regulatory Affairs, 1MED
14:45 – Coffee Break
15:15 – Contemporary 510K Experience
Roland Back - Director Regulatory Affairs EMEA, Abbott
Megha Iyer - Lead, Global Corporate Regulatory Affairs, Thermo Fisher Scientific
15:45 – International Regulatory Updates
Daniel Delfosse – Vice Director, Head of Regulation & Innovation, Swiss MedTech
Heather Rosecrans – VP of Regulatory Affairs, MDMA
Mia Spiegelman - Vice-President of Regulatory, Quality and Environmental Affairs, MedTech Canada
16:50 – Closing Remarks / Final Reflections
Sharon Lamb – Partner, McDermott Will & Schulte
17:00 – Event Close
Interested in becoming an exhibitor sponsor?
Write to ukevents@abhi.org.uk to explore your options.
Tickets
Early Bird rate expires on 8th August 2025.
SMEs are categorised as businesses with under 250 staff.
For bookings of more than five delegates, multi-buy discounts can be offered. Please write to ukevents@abhi.org.uk for more information.
Please note that a list of attendees (name and organisation) will be made available to delegates in advance of the event. If you would prefer not to be included on this list, please contact us at ukevents@abhi.org.uk
With thanks to our 2025 events partner:
Our event sponsors:
And our charity partner:
